Indication

Gestational trophoblastic neoplasia

Gestational trophoblastic neoplasia refers to a spectrum of rare, malignant pregnancy-related tumors arising from the abnormal proliferation of placental trophoblastic tissue within the female reproductive system. Read more about Gestational trophoblastic neoplasia

41 drugs 29 manufacturers

Advertisement

Drugs that treat it

Common Gestational trophoblastic neoplasia therapies.

Showing 1–9 of 41 drugs

Filter & compare in the drug finder →Opens the drug finder with Gestational trophoblastic neoplasia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Gestational trophoblastic neoplasia.

Gestational trophoblastic neoplasia refers to a spectrum of rare, malignant pregnancy-related tumors arising from the abnormal proliferation of placental trophoblastic tissue within the female reproductive system.

It encompasses invasive hydatidiform mole, choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor, which can develop after any gestation, most frequently following a molar pregnancy.

Pathophysiologically, these neoplasms exhibit local invasion into the myometrium and a pronounced tendency for early hematogenous dissemination, commonly to the lungs, vagina, and central nervous system.

Clinically, it is characterized by abnormal uterine bleeding, an enlarged uterus, and persistently elevated or plateauing levels of serum human chorionic gonadotropin.

Personalize your experience

Follow Gestational trophoblastic neoplasia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it